product Name：Furazabol
  • 17-Methyl-5-alpha-androstano(2,3-c)(1,2,5)oxadiazol-17-beta-ol; 17-Methyl-5alpha-androstano(2,3-c)furazan-17beta-ol; 17-beta-Hydroxy-17-alpha-methyl-5-alpha-androstano(2,3-c)furazan; Androfurazanol; DH 245; Frazalon; Furazabolo; Furazabolo [DCIT]; Furazabolum; Furazabolum [INN-Latin]; Miotolon; Myotolon; Qu Zhi Shu; UNII-2W07HSP5PX; 17-Methyl-5alpha-androstano(2,3-c)(1,2,5)oxadiazol-17beta-ol; 5-alpha-Androstano(2,3-c)(1,2,5)oxadiazol-17-beta-ol, 17-methyl-; 17alpha-Methyl-17beta-hydroxyandrostano(2,3-c)-furazan; (1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-2,3,3a,3b,4,5,5a,6,10,10a,10b,11,12,12a-tetradecahydro-1H-cyclopenta[7,8]phenanthro[2,3-c][1,2,5]oxadiazol-1-ol
  • 1239-29-8
  • 214-983-0
  • C20H30N2O2
  • 330.4644
  • InChI=1/C20H30N2O2/c1-18-11-17-16(21-24-22-17)10-12(18)4-5-13-14(18)6-8-19(2)15(13)7-9-20(19,3)23/h12-15,23H,4-11H2,1-3H3/t12-,13+,14-,15-,18-,19-,20-/m0/s1
  • Furazabol 1239-29-8
  • 1.145g/cm3
  • 445.6°C at 760 mmHg
  • 1.549
  • 223.3°C
  • 1.01E-08mmHg at 25°C